Immunosenescence, inflammaging, and cancer immunotherapy efficacy-Reference-Cited by-同舟云学术

Immunosenescence, inflammaging, and cancer immunotherapy efficacy

Published:2022-07-14 Issue:9 Volume:22 Page:915-926
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Rodriguez Julieta E¹,Naigeon Marie²³⁴,Goldschmidt Vincent¹,Roulleaux Dugage Matthieu¹²⁵,Seknazi Lauren¹,Danlos Francois X¹,Champiat Stephane¹,Marabelle Aurélien¹,Michot Jean-Marie¹,Massard Christophe¹,Besse Benjamin³⁵,Ferrara Roberto⁵⁶⁷,Chaput Nathalie²⁴,Baldini Capucine¹²

Affiliation:

1. Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France

2. Laboratory of Immunomonitoring in Oncology, Gustave Roussy Cancer Campus, Villejuif, France

3. School of Medicine, Paris-Saclay university, Kremlin Bicêtre, France

4. School of Pharmacy, Paris-Saclay University, Chatenay, France

5. Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France

6. Department of Medical Oncology, Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

7. Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

Funder

This paper received no funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2098718

Reference90 articles.

1. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

2. Engineering CAR-T Cells for Next-Generation Cancer Therapy

3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

4. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

5. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying an immunosenescence-associated gene signature in gastric cancer by integrating bulk and single-cell sequencing data;Scientific Reports;2024-07-24

2. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development;International Journal of Molecular Sciences;2024-06-11

3. Proteomic and metabolomic profiling of plasma predicts immune-related adverse events in older patients with advanced non-small cell lung cancer;iScience;2024-06

5. Machine learning-derived immunosenescence index for predicting outcome and drug sensitivity in patients with skin cutaneous melanoma;Genes & Immunity;2024-05-29